Frespaciguat
Frespaciguat (development code MK-5475) is an experimental inhaled soluble guanylate cyclase stimulator developed by Merck for pulmonary arterial hypertension
Frespaciguat (development code MK-5475) is an experimental inhaled soluble guanylate cyclase stimulator developed by Merck for pulmonary arterial hypertension
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors:
41-2272 BAY 41-8543 BAY 60-4552 BI-703704 Cinaciguat (BAY 58-2667) CY-3018 Frespaciguat GSK-2181236A Olinciguat Praliciguat Riociguat Vericiguat Zagociguat Inhibitors: